1.85
+7.56%
Close of 9 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About iTonic Holdings
Its shares trade under the ticker ITOC. It has been listed since 5 September 2024. In the fiscal year to 31 December 2025, it reported revenue of $523,031 and a net loss of $5.1m. At that date it held total assets of $9.1m and shareholders' equity of $6.1m.
Pheton Holdings Ltd is a CN-based company operating in Health Care Technology industry. The company is headquartered in Beijing, Beijing. The company went IPO on 2024-09-05. Pheton Holdings Ltd is a holding company principally engaged in the provision of healthcare solutions through its subsidiary Beijing Feitian Zhaoye Technology Co., Ltd. (Beijing Feitian). The Company’s main businesses include development and commercialization of brachytherapy treatment planning system (TPS) specifically used for radioactive particle implantation, a type of radiotherapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. TPS is generally a computer software used in different types of radiotherapy. The Company’s main product is FTTPS, a user-oriented TPS for treating a wide variety of malignant tumors. Beijing Feitian’s product portfolio also includes Medical Auxiliary Supplies such as seed implant needles, computer workstations, patient positioning device and others.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Health Care Technology
- Listed since
- 5 Sept 2024
- Employees
- 11
- Website
- ftzy.com.cn/ir/index.php ↗
- Head office
- ROOM 306, NET BUILDING, BEIJING
- Classification
- Electromedical & Electrotherapeutic Apparatus
- Filer status
- Non-accelerated filer<br>Emerging growth company
Leadership
Pay as last reported
- Mr. Jianfei ZhangChairman of the Board, Chief Executive Officer, since 2023
- Ms. Zhixin LiChief Financial Officer
- Mr. Pengfei ZhangDirector
- Mr. Swee Leng SengIndependent Director
- Mr. Yun Fai WongIndependent Director
- Mr. Edward YeIndependent Director
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Pheton Holdings Ltd employs 11 full-time employees in Beijing, China.
- Beijing Feitian Zhaoye Technology Co., Ltd. develops brachytherapy treatment planning systems for cancer treatment.
- FTTPS is a user-oriented TPS for treating various malignant tumors.
Weaknesses
- Pheton Holdings Ltd has a small employee count of 11 in the Health Care sector.
- Beijing Feitian's product portfolio includes medical auxiliary supplies like seed implant needles.
- The company's main business focuses on brachytherapy treatment planning systems.
Opportunities
- Pheton Holdings Ltd's brachytherapy TPS is used in cancer treatment for radioactive particle implantation.
- Beijing Feitian Zhaoye Technology Co., Ltd. provides healthcare solutions through its subsidiary.
- The company's main product FTTPS targets a wide range of malignant tumors.
Threats
- Pheton Holdings Ltd's IPO on 5 September 2024 may face market volatility.
- Beijing Feitian's focus on brachytherapy TPS could limit market expansion.
- The company's small size with 11 employees may hinder growth in the Health Care sector.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.